Welcome to our dedicated page for Encompass Health SEC filings (Ticker: EHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Encompass Health Corporation’s (NYSE: EHC) SEC filings, offering detailed insight into the company’s inpatient rehabilitation hospital business and financial profile. As the largest owner and operator of inpatient rehabilitation hospitals in the United States, Encompass Health uses its filings to report operating results, liquidity measures and other material information.
Current reports on Form 8-K included in the available information show how the company discloses quarterly financial results, updates to full-year guidance and investor materials. These filings reference metrics such as net operating revenue, Adjusted EBITDA, adjusted earnings per share, leverage ratio and adjusted free cash flow, along with explanations of why non-GAAP measures are used and how they are reconciled to comparable GAAP figures.
Other 8-K filings address topics like publication of an Investor Reference Book, which provides an overview of the company and its industry, business outlook, growth strategy and operational initiatives, as well as Regulation FD communications when senior management meets with investors and analysts. Governance-related 8-Ks can also appear, such as notices of director departures.
Through this filings page, users can review Encompass Health’s earnings-related 8-Ks, Regulation FD disclosures and other material event reports as they are made available via EDGAR. AI-powered tools on the platform can help summarize lengthy documents, highlight key metrics and clarify definitions of non-GAAP measures like Adjusted EBITDA and adjusted free cash flow, making it easier to understand how the company evaluates performance, manages leverage and plans for growth.
For anyone analyzing EHC stock, these SEC filings are a primary source for understanding Encompass Health’s financial condition, risk disclosures, capital structure and strategic communications with investors.
Encompass Health Corp President and CEO Mark J. Tarr reported a tax-related share disposition. On the transaction date, 2,488 shares of Encompass Health common stock were withheld at
Encompass Health Corp senior vice president and treasurer Edmund Fay reported a small insider share disposition related to equity compensation. On the transaction date, 380 shares of Encompass Health common stock were withheld at a price of $106.15 per share to cover tax obligations from vesting restricted stock, leaving him with 101,542 directly held shares.
Encompass Health Corp executive Patrick William Tuer, EVP and Chief Operating Officer, reported a tax-related share disposition. On the reported date, 506 shares of Encompass Health common stock were withheld or surrendered at
Encompass Health Corp EVP & Chief Financial Officer Douglas E. Coltharp reported a Form 4 transaction involving Encompass Health Common Stock. On February 23, 2026, 14,818 shares were disposed of at $106.15 per share under code F, which indicates a tax-withholding disposition to satisfy tax obligations tied to vesting restricted stock, rather than an open-market sale. After this withholding event, he directly owns 70,153 shares, with additional indirect holdings reported through an irrevocable trust, an irrevocable trust for the benefit of his children, and his spouse.
Encompass Health Corp Chief Accounting Officer Andrew L. Price disposed of 404 shares of Encompass Health common stock on a tax-withholding basis. The shares, valued at $106.15 each, were withheld to cover taxes due upon vesting of related restricted stock. After this transaction, Price held 75,001 shares directly.
Encompass Health Corp’s Chief Medical Officer, Elissa Joy Charbonneau, reported a tax-related share disposition. On this Form 4, 440 shares of Encompass Health common stock were withheld to cover tax obligations from vesting restricted stock, at a reference price of
Encompass Health Corp executive John Patrick Darby reported a tax-related share disposition. On February 23, 2026, he disposed of 6,990 shares of Encompass Health common stock at a price of $106.15 per share to cover tax withholding obligations tied to vesting restricted stock.
After this tax-withholding transaction, Darby directly owned 84,363 shares of Encompass Health common stock. The filing describes the event as shares withheld or surrendered to pay tax liabilities, rather than an open-market sale.
Encompass Health Corp's chief medical officer, Elissa Joy Charbonneau, reported two share dispositions tied to tax withholding on vested restricted stock. On February 19, 2026, 4,016 Encompass Health common shares were withheld at
Encompass Health Corp President & CEO Mark J. Tarr reported two tax-related share dispositions of Encompass Health common stock. On February 19, 43,378 shares were withheld at
According to the disclosure, these shares were withheld or surrendered to cover tax withholding obligations tied to the vesting of restricted stock, rather than open-market sales. After these transactions, Tarr directly owned 445,637 Encompass Health shares.
Encompass Health Corp senior vice president and treasurer Edmund Fay reported two tax-related share dispositions in Encompass Health common stock. On February 19, 3,479 shares were withheld at